𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations

✍ Scribed by Gabriella Santangelo; Luigi Trojano; Carmine Vitale; Marta Ianniciello; Marianna Amboni; Dario Grossi; Paolo Barone


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
82 KB
Volume
22
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The aim of this work was to determine the progression of cognitive impairment in Parkinson's disease (PD) patients with or without hallucinations. Two years after the first assessment, 36 PD patients were re‐evaluated on standardized neuropsychological tests, including the Frontal Assessment Battery (FAB), and on rating scales for overall cognitive functioning, functional autonomy, behavioral disorders. Nine patients had hallucinations at baseline and endpoint assessments; 12 patients developed hallucinations during the follow‐up; and 15 patients were hallucination‐free throughout the study. Cognitive performance significantly declined in all three groups, but at endpoint assessment PD hallucinators scored significantly lower than nonhallucinators on phonological and semantic fluency tasks, immediate free recall and the go/no‐go FAB subtest; moreover, they showed more severe apathy than nonhallucinators. Reduced phonological fluency at baseline (odds ratio [OR], 13.5; 95% CI: 1.34–135.98, P = 0.027) was the only independent predictor of onset of hallucinations after 2 years, whereas hallucinations (OR, 10.1; 95% CI: 1.94–51.54, P = 0.006) and poor phonological fluency (OR, 6.1; 95% CI: 1.04–35.03, P = 0.045) independently predicted development of diffuse cognitive impairment. We concluded that reduced verbal fluency scores may predict the onset of hallucinations, while hallucinations and poor phonological fluency may predict development of dementia in PD patients. © 2007 Movement Disorder Society


📜 SIMILAR VOLUMES


Neuropsychological deficits in Parkinson
✍ Blanca Ramírez-Ruiz; Carme Junqué; María-José Martí; Francesc Valldeoriola; Edua 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

## Abstract Recent neuropathological and neuroimaging studies suggest the involvement of several temporal regions in Parkinson's disease (PD) patients with visual hallucinations (VH). We examined 24 nondemented PD patients with VH, 21 PD patients without VH, and 21 healthy controls using a battery

A longitudinal study of neuropsychologic
✍ Tamiko Azuma; Robyn F. Cruz; Kathryn A. Bayles; Cheryl K. Tomoeda; Erwin B. Mont 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract Neuropsychological changes in individuals with Parkinson's disease (PD) were studied longitudinally. Sixty‐nine idiopathic PD patients, with Mini‐Mental State Examination (MMSE) scores falling within normal range, and 37 elderly control participants were given neuropsychological tests t

A longitudinal study of neuropsychologic
✍ Tamiko Azuma; Robyn F. Cruz; Kathryn A. Bayles; Cheryl K. Tomoeda; E. B. Montgom 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

## Abstract ## Objectives Neuropsychological changes in individuals with Parkinson's disease (PD) were studied longitudinally. ## Methods Sixty‐nine idiopathic PD patients, with Mini‐Mental State Examination (MMSE) scores falling within normal range, and 37 elderly control participants were give

Effects of rivastigmine in patients with
✍ David Burn; Murat Emre; Ian McKeith; Peter Paul De Deyn; Dag Aarsland; Chuanchie 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

## Abstract We aimed to determine prospectively whether rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase, provided benefits in patients with and without visual hallucinations in a population with dementia associated with Parkinson's disease (PDD). This was a 24‐week doub

Predictors of health care use in patient
✍ Angela G. E. M. de Boer; Mirjam A. G. Sprangers; Hans D. Speelman; Hanneke C. J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

PURPOSE: To predict health care use in patients with Parkinson's disease. METHODS: The health care use of 235 patients with Parkinson's disease was studied twice over the course of 1 year. Use consisted of visits to the neurologist and general practitioner (GP) and use of a physiotherapist, a psych